Pages Menu
FacebookTwitterPinterestRss
Categories Menu

IntraBio


This page is dedicated to news and information about IntraBio’s therapies for use in Niemann-Pick Disease Type C (NPC).
Information is released as it becomes available.

CLINICALTRIALS.GOV

ABOUT INTRABIO     GLOSSARY OF TERMS


IntraBio Investigational New Drug Application Approved by the FDA for the Treatment of NPC

.
CLICK HERE FOR COMPLETE ANNOUNCEMENT

02/13/2019 jjb

IntraBio Receives Niemann-Pick Disease Orphan Drug Designation from the FDA for IB1000 Series

.
CLICK HERE FOR COMPLETE ANNOUNCEMENT

11/26/2018 jjb

 

FACEBOOK
TWITTER
PINTEREST